Innovatus Life Sciences Acquisition Corp.

Innovatus Life Sciences Acquisition Corp. (Nasdaq: ILAC) is a blank-check company sponsored by an affiliate of Innovatus Capital Partners, a healthcare-focused investment firm, and was formed to pursue a business combination in the life sciences and healthcare sector. The company filed its amended S-1 registration statement with the SEC in June 2021, with its initial public offering completing that same year. ILAC targeted opportunities across biopharmaceuticals, medical devices, diagnostics, and related healthcare sub-sectors. For the most current information on ILAC's deal status, filings, and sponsor disclosures, visit SpacDesk and sign up for full access to our comprehensive SPAC data and research platform.